Business Tech
Shanghai Electric wins Unit 3 contract at Malaysian CCGT project
The company said it will supply a full EPC turnkey solution and a 25-year service agreement covering major equipment.
Health
Phase III trial reports survival gain for anti-B7-H3 antibody-drug conjugate in relapsed small-cell lung cancer
The TAISHAN-302 study found tambotatug pelitecan improved overall survival, progression-free survival and response rates compared with topotecan, according to results presented at the IASLC 2026 World Conference on Lung Cancer.
Health
Sacituzumab Govitecan Plus Pembrolizumab Fails to Show Statistically Significant PFS Benefit in PD-L1-High NSCLC
Primary results from the Phase 3 EVOKE-03/KEYNOTE-D46 trial showed numerically longer progression-free survival with the combination but did not meet the prespecified threshold for statistical significance.
